Alps Global Holding Berhad aims to revolutionise healthcare through biotechnology research and wellness services, focusing on personalised and precision medicine to reduce costs. Group CEO Dr Tham Seng Kong discusses the challenges of high costs and failure rates in biotech, emphasising their strategy to control the entire supply chain for more affordable treatments.

See omnystudio.com/listener for privacy information.